• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

约氏疟原虫作为疟疾模型:对发病机制、耐药性及疫苗研发的见解

Plasmodium yoelii as a model for malaria: insights into pathogenesis, drug resistance, and vaccine development.

作者信息

Otun Oluwatobi, Achilonu Ikechukwu

机构信息

Protein Structure-Function Unit, Department of Molecular and Cell Biology, University of Witwatersrand, Johannesburg, South Africa.

出版信息

Mol Biol Rep. 2025 Feb 5;52(1):208. doi: 10.1007/s11033-025-10318-4.

DOI:10.1007/s11033-025-10318-4
PMID:39907835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11799112/
Abstract

Malaria continues to pose a serious global health threat, with rising drug resistance making treatment more difficult. Consequently, Plasmodium yoelii, a rodent malaria parasite, has become an invaluable model for studying the malaria parasite's complex biology, particularly host-parasite interactions and drug resistance mechanisms. Originating from African rodents, P. yoelii presents unique genetic diversity, mirroring critical aspects of human malaria and allowing for detailed research on the parasite's pre-erythrocytic and erythrocytic stages. This review introduces a novel perspective by comprehensively examining P. yoelii from multiple angles, including its origin, genetic composition, and contributions to vaccine development and drug efficacy studies. It highlights the significance of P. yoelii, revealing new insights into immune evasion, pathogenesis, and disease severity, which are critical for developing future malaria interventions. Furthermore, this review addresses the challenges associated with P. yoelii as a model, such as differences in host immune responses between rodents and humans. Despite these hurdles, the research using P. yoelii offers promising directions for combating malaria. This novel synthesis of P. yoelii studies underscores its essential role in advancing malaria research, particularly in understanding drug resistance and uncovering potential therapeutic and vaccine targets.

摘要

疟疾仍然对全球健康构成严重威胁,耐药性不断上升使治疗变得更加困难。因此,约氏疟原虫(一种啮齿动物疟原虫)已成为研究疟原虫复杂生物学,特别是宿主 - 寄生虫相互作用和耐药机制的宝贵模型。约氏疟原虫起源于非洲啮齿动物,具有独特的遗传多样性,反映了人类疟疾的关键方面,并允许对该寄生虫的红细胞前期和红细胞期进行详细研究。本综述通过从多个角度全面审视约氏疟原虫,包括其起源、遗传组成以及对疫苗开发和药物疗效研究的贡献,引入了一种新的视角。它强调了约氏疟原虫的重要性,揭示了对免疫逃避、发病机制和疾病严重程度的新见解,这些对于开发未来的疟疾干预措施至关重要。此外,本综述还讨论了将约氏疟原虫作为模型所面临的挑战,例如啮齿动物和人类宿主免疫反应的差异。尽管存在这些障碍,但使用约氏疟原虫的研究为抗击疟疾提供了有希望的方向。这种对约氏疟原虫研究的新颖综合强调了其在推进疟疾研究,特别是在理解耐药性和发现潜在治疗及疫苗靶点方面的重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb1/11799112/f43dffcbae0b/11033_2025_10318_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb1/11799112/f43dffcbae0b/11033_2025_10318_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb1/11799112/f43dffcbae0b/11033_2025_10318_Fig1_HTML.jpg

相似文献

1
Plasmodium yoelii as a model for malaria: insights into pathogenesis, drug resistance, and vaccine development.约氏疟原虫作为疟疾模型:对发病机制、耐药性及疫苗研发的见解
Mol Biol Rep. 2025 Feb 5;52(1):208. doi: 10.1007/s11033-025-10318-4.
2
A new malaria antigen produces partial protection against Plasmodium yoelii challenge.一种新的疟原虫抗原可产生针对约氏疟原虫感染的部分保护作用。
Parasitol Res. 2012 Apr;110(4):1337-45. doi: 10.1007/s00436-011-2630-y. Epub 2011 Sep 14.
3
Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.用于啮齿动物疟原虫约氏疟原虫的改进转染方法和新的选择标记
Mol Biochem Parasitol. 2006 Apr;146(2):242-50. doi: 10.1016/j.molbiopara.2006.01.001. Epub 2006 Jan 17.
4
Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates.鉴定两种新的红细胞前期保护性疟疾疫苗抗原候选物。
Malar J. 2011 Mar 16;10:65. doi: 10.1186/1475-2875-10-65.
5
Gene targeting in the rodent malaria parasite Plasmodium yoelii.啮齿动物疟原虫约氏疟原虫中的基因靶向
Mol Biochem Parasitol. 2001 Apr 6;113(2):271-8. doi: 10.1016/s0166-6851(01)00228-6.
6
Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection.约氏疟原虫感染小鼠模型中重复间断治疗的体内耐药性选择
Malar J. 2017 May 23;16(1):216. doi: 10.1186/s12936-017-1860-6.
7
Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.青蒿琥酯抗疟感染-治疗-疫苗接种方案定义了与疟原虫 yoelii 早前期和红细胞期感染的长期无菌保护相关的阶段特异性免疫反应。
J Immunol. 2014 Aug 1;193(3):1268-77. doi: 10.4049/jimmunol.1400296. Epub 2014 Jun 23.
8
Isolation and Characterization of Vaccine Candidate Genes Including and in .包括[具体基因名称1]和[具体基因名称2]在内的疫苗候选基因在[具体物种或环境等]中的分离与鉴定
Korean J Parasitol. 2017 Jun;55(3):255-265. doi: 10.3347/kjp.2017.55.3.255. Epub 2017 Jun 30.
9
The Consequences of Mixed-Species Malaria Parasite Co-Infections in Mice and Mosquitoes for Disease Severity, Parasite Fitness, and Transmission Success.混合种疟原虫寄生虫感染在小鼠和蚊子中的后果,对疾病严重程度、寄生虫适应性和传播成功率的影响。
Front Immunol. 2020 Jan 22;10:3072. doi: 10.3389/fimmu.2019.03072. eCollection 2019.
10
Isolation of invasive Plasmodium yoelii merozoites with a long half-life to evaluate invasion dynamics and potential invasion inhibitors.分离具有长半衰期的侵袭性约氏疟原虫裂殖子以评估侵袭动力学和潜在的侵袭抑制剂。
Mol Biochem Parasitol. 2015 Nov;204(1):26-33. doi: 10.1016/j.molbiopara.2015.12.003. Epub 2015 Dec 9.

本文引用的文献

1
Animal models for exploring Chagas disease pathogenesis and supporting drug discovery.用于探索恰加斯病发病机制及支持药物研发的动物模型。
Clin Microbiol Rev. 2024 Dec 10;37(4):e0015523. doi: 10.1128/cmr.00155-23. Epub 2024 Nov 15.
2
Polymorphisms in the Pfcrt, Pfmdr1, and Pfk13 genes of Plasmodium falciparum isolates from southern Brazzaville, Republic of Congo.来自刚果共和国布拉柴维尔南部的恶性疟原虫分离株中 Pfcrt、Pfmdr1 和 Pfk13 基因的多态性。
Sci Rep. 2024 Nov 14;14(1):27988. doi: 10.1038/s41598-024-78670-2.
3
Overview of spp. and Animal Models in Malaria Research.
疟疾研究中的疟原虫种类及动物模型概述。
Comp Med. 2024 Aug 1;74(4):205-230. doi: 10.30802/AALAS-CM-24-000019. Epub 2024 Jun 20.
4
Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle.疟疾疫苗研发的进展与挑战:针对疟原虫生命周期的多个阶段
ACS Infect Dis. 2023 Oct 13;9(10):1795-1814. doi: 10.1021/acsinfecdis.3c00332. Epub 2023 Sep 14.
5
Statin and aspirin use in parasitic infections as a potential therapeutic strategy: A narrative review.他汀类药物和阿司匹林在寄生虫感染中的应用作为一种潜在治疗策略:一篇叙述性综述。
Rev Argent Microbiol. 2023 Jul-Sep;55(3):278-288. doi: 10.1016/j.ram.2023.01.006. Epub 2023 Apr 3.
6
CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification.疟原虫中的CRISPR-Cas13:诊断与潜在基因功能鉴定
Front Microbiol. 2023 Jan 25;14:1076947. doi: 10.3389/fmicb.2023.1076947. eCollection 2023.
7
Development and Optimization of a Selective Whole-Genome Amplification To Study Plasmodium ovale Spp.开发和优化选择性全基因组扩增技术以研究卵形疟原虫 spp.
Microbiol Spectr. 2022 Oct 26;10(5):e0072622. doi: 10.1128/spectrum.00726-22. Epub 2022 Sep 13.
8
The origins, isolation, and biological characterization of rodent malaria parasites.啮齿类疟原虫的起源、分离和生物学特性。
Parasitol Int. 2022 Dec;91:102636. doi: 10.1016/j.parint.2022.102636. Epub 2022 Aug 1.
9
Genetic mapping of determinants in drug resistance, virulence, disease susceptibility, and interaction of host-rodent malaria parasites.药物抗性、毒力、疾病易感性以及宿主-鼠疟原虫相互作用决定因素的遗传图谱。
Parasitol Int. 2022 Dec;91:102637. doi: 10.1016/j.parint.2022.102637. Epub 2022 Aug 1.
10
Dissecting Pathobiology: Proteomic Approaches for Decoding Novel Translational and Post-Translational Modifications.剖析病理生物学:用于解码新型翻译后修饰和翻译后修饰的蛋白质组学方法。
ACS Omega. 2022 Mar 2;7(10):8246-8257. doi: 10.1021/acsomega.1c03892. eCollection 2022 Mar 15.